Mark Peplow's Critical point

  • CW0415_Critical-point_630m
    Opinion

    Thinking ahead

    26 March 2015

    PhD courses must prepare students for a life after research, says Mark Peplow

  • DPA Picture Alliance / Alamy
    Opinion

    A large life, fully lived

    20 February 2015

    Carl Djerassi leaves many legacies besides the contraceptive pill,says Mark Peplow

  • 0215CW_Criticalpoint_630m
    Opinion

    The big experiment

    23 January 2015

    Plans to stop assessing school pupils’ practical work are the wrong solution to a genuine problem, says Mark Peplow

  • CW0115_Critical-point_300tb
    Opinion

    A bad business

    19 December 2014

    Targets and assessments can boost productivity at universities – but only if they do not stifle creativity and alienate the academic workforce, says Mark Peplow

  • CW1214_CriticalPoint_630m
    Opinion

    It's time to speak up for Europe

    27 November 2014

    Researchers in the UK benefit enormously from their country’s membership of the EU. They need to say so, argues Mark Peplow

  • CW1114_Critical-point_630m
    Opinion

    Two for the price of one

    23 October 2014

    This year’s Nobel prizes show that chemistry truly is the central science

  • CW1014_Criticalpoint_300tb
    Opinion

    Good advice

    25 September 2014

    Rather than axing his chief scientific adviser, the next president of the European commission should enhance the role

  • CW0914_CriticalPoint_630m
    Opinion

    The trouble with boycotts

    29 August 2014

    Cutting academic ties with a censured state can do more harm than good, says Mark Peplow

  • CW0814_Criticalpoint_630m
    Opinion

    The creative stimulus

    22 July 2014

    Innovative thinking may be difficult to turn on at will, but there are many ways to prepare for inspiration, says Mark Peplow

  • CW0714_CriticalPoint_630m
    Opinion

    A mind-blowing legacy

    11 June 2014

    Alexander Shulgin’s research on psychoactive drugs shows how molecules can take on a life of their own once they leave the lab, says Mark Peplow